http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H01279829-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44c713790ce00813da2e6c6d57a29456
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
filingDate 1988-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84156d4b3efa9ebe9ac08b96d29ea2ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_374a2da489e2f1ee18ce0289c158a3e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5b5e43e70b3e02959291d02929a06a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31011b68263bc37bbf37d0c17fd82c9c
publicationDate 1989-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H01279829-A
titleOfInvention Vitamin e composition
abstract PURPOSE:To obtain the subject composition, good in dispersibility in gastric juice, etc., in internal use, improved in absorbability, and effective in preventing formation of peroxylipids, etc., by blending vitamin E with a polyoxyethylene sorbitan ester and sorbitan dioleate in a specific proportion. CONSTITUTION:A vitamin E composition obtained by blending a polyoxyethylene sorbitan ester with sorbitan dioleate which are active ingredients respectively at 9:1-6:4 blending ratio therein. For example, polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbitan monopalmitate, etc., are cited as the polyoxyethylene sorbitan ester. The blending ratio of the vitamin E is 0.8-1.2 if the total blended amount of the polyoxyethylene sorbitan ester and sorbitan dioleate is 1. In preparing a pharmaceutical, polyhydric alcohols, such as polyethylene glycol, may be added in an amount of 5-10 times based on the total pharmaceutical.
priorityDate 1988-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226429226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10953859
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426254016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73950339
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID103023
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6610295

Total number of triples: 30.